BIO BLAST PHARMA LTD's ticker is ORPN and the CUSIP is M20156101. A total of 10 filers reported holding BIO BLAST PHARMA LTD in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $4,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 338,110 | $2,458,000 | 0.96% |
| DSC Advisors, L.P. | 114,602 | $833,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,091,000 | 0.14% |
| Visium Asset Management, LP | 627,000 | $4,558,000 | 0.07% |
| Ground Swell Capital, LLC | 689 | $5,000 | 0.01% |
| Soros Fund Management | 71,254 | $518,000 | 0.00% |
| MORGAN STANLEY | 24 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 300 | $2,000 | 0.00% |
| UBS AG | 498 | $4,000 | 0.00% |